The molecular evolution of HIV-1 Protease simulated at atomic detail

被引:3
作者
Tiana, G. [1 ,2 ]
Broglia, R. A. [1 ,2 ,3 ]
机构
[1] Univ Milan, Dept Phys, I-20133 Milan, Italy
[2] Ist Nazl Fis Nucl, I-20133 Milan, Italy
[3] Niels Bohr Inst, DK-2100 Copenhagen, Denmark
关键词
evolution; computational models; HIV-1; protease; MODEL; STABILITY; DESIGN; PROTEINS; RESISTANCE; LANDSCAPE; DYNAMICS; DATABASE;
D O I
10.1002/prot.22395
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Progress in understanding protein folding allows to simulate, with atomic detail, the evolution of amino-acid sequences folding to a given native conformation. A particularly attractive example is the HIV-1 protease, main target of therapies to fight AIDS, which under drug pressure is able to develop resistance within few months from the starting of therapy. By comparing the results of simulations of the evolution of the protease with the corresponding proteomic data, one can approximately determine the value of the associated evolution pressure under which the enzyme has become and, as a consequence, map (out the energy landscape in sequence space of the HIV-1 protease. It is found that there are several families of sequences folding to the native conformations of the enzyme. Each of these families are characterized by different sets of highly conserved ("hot") amino acids which play a critical role in the folding and stability of the protease. There are two main possibilities for the virus to move from one family to a different one: (a) in a single generation, through the concerted mutations of the hot amino acids, a highly unlikely event, (b) through a folding path (if it exists), again a very improbable event. In fact, the number of generations needed by the virus to change stepwise its sequence from one family to another is astronomically large. These results point to the "hot" segments of the protease as promising targets for a non-conventional inhibition strategy, likely not to create resistance.
引用
收藏
页码:895 / 910
页数:16
相关论文
共 47 条
[1]   SPECIFIC NUCLEUS AS THE TRANSITION-STATE FOR PROTEIN-FOLDING - EVIDENCE FROM THE LATTICE MODEL [J].
ABKEVICH, VI ;
GUTIN, AM ;
SHAKHNOVICH, EI .
BIOCHEMISTRY, 1994, 33 (33) :10026-10036
[2]  
Branden C.I., 1999, INTRO PROTEIN STRUCT
[3]   HIV-1 protease folding and the design of drugs which do not create resistance [J].
Broglia, R. A. ;
Levy, Y. ;
Tiana, G. .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2008, 18 (01) :60-66
[4]   The physics of protein folding and of non-conventional drug design: Attacking AIDS with its own weapons [J].
Broglia, R. A. ;
Tiana, G. ;
Sutto, L. ;
Provasi, D. ;
Simona, F. .
RIVISTA DEL NUOVO CIMENTO, 2006, 29 (3-4) :1-119
[5]   A folding inhibitor of the HIV-1 protease [J].
Broglia, RA ;
Provasi, D ;
Vasile, F ;
Ottolina, G ;
Longhi, R ;
Tiana, G .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2006, 62 (04) :928-933
[6]   Design of HIV-1-PR inhibitors that do not create resistance: Blocking the folding of single monomers [J].
Broglia, RA ;
Tiana, G ;
Sutto, L ;
Provasi, D ;
Simona, F .
PROTEIN SCIENCE, 2005, 14 (10) :2668-2681
[7]   Hierarchy of events in the folding of model proteins [J].
Broglia, RA ;
Tiana, G .
JOURNAL OF CHEMICAL PHYSICS, 2001, 114 (16) :7267-7273
[8]  
COFFIN JM, 1995, SCIENCE, V373, P382
[9]   RANDOM-ENERGY MODEL - AN EXACTLY SOLVABLE MODEL OF DISORDERED-SYSTEMS [J].
DERRIDA, B .
PHYSICAL REVIEW B, 1981, 24 (05) :2613-2626
[10]   Emergence of protein fold families through rational design [J].
Ding, Feng ;
Dokholyan, Nikolay V. .
PLOS COMPUTATIONAL BIOLOGY, 2006, 2 (07) :725-733